Timothy Van Hauwermeiren
Co-Founder & Non-Independent Non-Executive Chairman of the BoardMr. Timothy Van Hauwermeiren, also known as Tim, MSc, EMBA, serves as Independent Non-Executive Director of Lexeo Therapeutics, Inc since July 2024. He had been Independent Director at iTeos Therapeutics, Inc. since June 2018 until June 01, 2025. Mr. Van Hauwermeiren has general management and business development experience across the life sciences and consumer goods sectors. Mr. Van Hauwermeiren is Member of Advisory Board of Forbion Growth Opportunities Fund since July 2020. He is Non-Independent Non-Executive Chairman of the Board of argenx SE since May 6, 2026 and was its Chief Executive Officer and Executive Director since April 2008 and July 9, 2014 respectively to May 6, 2026 and is its Founder. Mr. Van Hauwermeiren is the Co-Founder of Argenx SE since 2008. He served as Director of Management Board at argenx SE since July 15, 2008. Mr. Van Hauwermeiren served as the Business Development Manager of Ablynx NV. He serves as Director at Aelin Therapeutics. He developed broad business development and operational management experience as Senior Business Development Manager at Ablynx NV. Mr. Van Hauwermeiren has general management and business development experience across the life sciences and consumer goods sectors. Prior to joining Ablynx, Mr. Van Hauwermeiren has held various management positions with the Procter & Gamble Company in R&D and Corporate New Business Development, where he conceived and developed several new to the world products. He is an Independent Director of Optidrive, a High-Tech spin-off from the University of Leuven. Mr. Van Hauwermeiren previously served on the Board of Directors of RayzeBio, Inc. from November 2023 until February 2024, when it was acquired by Bristol-Myers Squibb Company. Mr. Van Hauwermeiren holds B.Sc. and Master of Science degree in Bio-Engineering from the University of Gent and received general management training at INSEAD. He also holds Executive MBA from The Vlerick School of Management.
Positions
- Company Nameargenx SEStock CodeARGXPositionCo-Founder & Non-Independent Non-Executive Chairman of the BoardColleagues
- KMKaren MasseyCEO & Executive Director
- KGKarl GubitzChief Financial Officer
- PUPeter UlrichtsChief Scientific Officer
- MMMalini MoorthyGeneral Counsel & Corporate Secretary
- AAAnthony A. RosenbergIndependent Vice Chairman
- HDHans de HaardCo-Founder & Member of Board Advisors
- ACAna CespedesIndependent Non-Executive Director
